Diagnostic odyssey of patients with myotonic dystrophy

Journal of Neurology

Volumn 260, Issue 10, 2013, Pages 2497-2504

  Hilbert, James E ^a   Ashizawa, Tetsuo ^b   Day, John W ^c   Luebbe, Elizabeth A ^a   Martens, William B ^a   McDermott, Michael P ^a   Tawil, Rabi ^a   Thornton, Charles A ^a   Moxley III, Richard T ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Clinical care guidelines; Facioscapulohumeral muscular dystrophy; Muscular dystrophy; Myotonic dystrophy; Registry

Indexed keywords

ADULT; ARTICLE; ELECTROMYOGRAPHY; GENETIC SCREENING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUSCLE BIOPSY; MYOTONIA; MYOTONIC DYSTROPHY; PAIN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE OF ONSET; DELAYED DIAGNOSIS; ELECTROMYOGRAPHY; FEMALE; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; REGISTRIES; TIME FACTORS; YOUNG ADULT;

EID: 84886092997     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-6993-0     Document Type: Article

References (50)

1. Harper PS (2001) Myotonic dystrophy. W.B Saunders Company, London
2. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T, Sohn R, Zemelman B, Snell RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 68:799-808
3. Fu YH, Pizzuti A, Fenwick RG Jr, King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, Wieringa B, Korneluk R, Perryman MB, Epstein HF, Caskey CT (1992) An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255:1256-1258
4. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barcelo J, O'Hoy K, Leblond S, Earle-MacDonald J, De Jong P, Wieringa B, Korneluk R (1992) Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 255:1253-1255
5. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864-867
6. Ranum LP, Rasmussen PF, Benzow KA, Koob MD, Day JW (1998) Genetic mapping of a second myotonic dystrophy locus. Nat Genet 19:196-198
7. Cho DH, Tapscott SJ (2007) Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim Biophys Acta 1772:195-204
8. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, Schneider C, Koch MC, Beilman GJ, Harrison AR, Dalton JC, Ranum LP (2003) Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60:657-664
9. Osborne RJ, Thornton CA (2006) RNA-dominant diseases. Hum Mol Genet 15 Spec No 2:R162-R169
10. Udd B, Krahe R (2012) The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 11:891-905
11. Douniol M, Jacquette A, Cohen D, Bodeau N, Rachidi L, Angeard N, Cuisset JM, Vallee L, Eymard B, Plaza M, Heron D, Guile JM (2012) Psychiatric and cognitive phenotype of childhood myotonic dystrophy type 1. Dev Med Child Neurol 54:905-911
12. Schara U, Schoser BG (2006) Myotonic dystrophies type 1 and 2: a summary on current aspects. Semin Pediatr Neurol 13:71-79
13. Ricker K, Koch MC, Lehmann-Horn F, Pongratz D, Otto M, Heine R, Moxley RT (1994) Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness and cataracts. Neurology 44:1448-1452
14. Thornton CA, Griggs RC, Moxley RT (1994) Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol 35:269-272
15. Meola G, Moxley RT III (2004) Myotonic dystrophy type 2 and related myotonic disorders. J Neurol 251:1173-1182
16. Udd B, Meola G, Krahe R, Wansink DG, Bassez G, Kress W, Schoser B, Moxley R (2011) Myotonic dystrophy type 2 (DM2) and related disorders Report of the 180th ENMC Workshop including guidelines on diagnostics and management 3-5 December 2010, Naarden, The Netherlands. Neuromuscul Disord 21:443-450
17. Gaul C, Schmidt T, Windisch G, Wieser T, Muller T, Vielhaber S, Zierz S, Leplow B (2006) Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2). Neurology 67:350-352
18. Minnerop M, Weber B, Schoene-Bake JC, Roeske S, Mirbach S, Anspach C, Schneider-Gold C, Betz RC, Helmstaedter C, Tittgemeyer M, Klockgether T, Kornblum C (2011) The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain 134:3530-3546
19. Franc DT, Muetzel RL, Robinson PR, Rodriguez CP, Dalton JC, Naughton CE, Mueller BA, Wozniak JR, Lim KO, Day JW (2012) Cerebral and muscle MRI abnormalities in myotonic dystrophy. Neuromuscul Disord 22:483-491
20. Kornblum C, Reul J, Kress W, Grothe C, Amanatidis N, Klockgether T, Schroder R (2004) Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2. J Neurol 251:710-714
21. Meola G, Sansone V, Perani D, Scarone S, Cappa S, Dragoni C, Cattaneo E, Cotelli M, Gobbo C, Fazio F, Siciliano G, Mancuso M, Vitelli E, Zhang S, Krahe R, Moxley RT (2003) Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscul Disord 13:813-821
22. Sansone V, Gandossini S, Cotelli M, Calabria M, Zanetti O, Meola G (2007) Cognitive impairment in adult myotonic dystrophies: a longitudinal study. Neurol Sci 28:9-15
23. Hilbert JE, Luebbe EA, Martens WB, Moxley RT III, Registry Scientific Advisory Committee (2009) Diagnostic odyssey of myotonic dystrophy type 2 (DM2) patients, Poster P4-08; 9th international myotonic dystrophy consortium meeting; Wurzburg Germany. Med Gen 21:444
24. Milone M, Batish SD, Daube JR (2009) Myotonic dystrophy type 2 with focal asymmetric muscle weakness and no electrical myotonia. Muscle Nerve 39:383-385
25. Young NP, Daube JR, Sorenson EJ, Milone M (2010) Absent, unrecognized, and minimal myotonic discharges in myotonic dystrophy type 2. Muscle Nerve 41:758-762
26. Auvinen S, Suominen T, Hannonen P, Bachinski LL, Krahe R, Udd B (2008) Myotonic dystrophy type 2 found in two of sixty-three persons diagnosed as having fibromyalgia. Arthritis Rheum 58:3627-3631
27. Suominen T, Bachinski LL, Auvinen S, Hackman P, Baggerly KA, Angelini C, Peltonen L, Krahe R, Udd B (2011) Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. Eur J Hum Genet 19:776-782
28. Foff EP, Mahadevan MS (2011) Therapeutics development in myotonic dystrophy type 1. Muscle Nerve 44:160-169
29. Lee JE, Bennett CF, Cooper TA (2012) RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1. Proc Natl Acad Sci USA 109:4221-4226
30. Wheeler TM, Leger AJ, Pandey SK, MacLeod AR, Nakamori M, Cheng SH, Wentworth BM, Bennett CF, Thornton CA (2012) Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 488:111-115
31. Hilbert JE, Kissel JT, Luebbe EA, Martens WB, McDermott MP, Sanders DB, Tawil R, Thornton CA, Moxley RT III (2012) If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD). Contemp Clin Trials 33:302-311
32. Heatwole C, Bode R, Johnson N, Quinn C, Martens W, McDermott MP, Rothrock N, Thornton C, Vickrey B, Victorson D, Moxley R III (2012) Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology 79:348-357
33. Rubinstein YR, Groft SC, Bartek R, Brown K, Christensen RA, Collier E, Farber A, Farmer J, Ferguson JH, Forrest CB, Lockhart NC, McCurdy KR, Moore H, Pollen GB, Richesson R, Miller VR, Hull S, Vaught J (2010) Creating a global rare disease patient registry linked to a rare diseases biorepository database: rare disease-HUB (RD-HUB). Contemp Clin Trials 31:394-404
34. Thompson R, Schoser B, Monckton DG, Blonsky K, Lochmuller H (2009) Patient Registries and Trial Readiness in Myotonic Dystrophy-TREAT-NMD/Marigold International Workshop Report. Neuromuscul Disord 19:860-866
35. Ciafaloni E, Fox DJ, Pandya S, Westfield CP, Puzhankara S, Romitti PA, Mathews KD, Miller TM, Matthews DJ, Miller LA, Cunniff C, Druschel CM, Moxley RT (2009) Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). J Pediatr 155:380-385
36. Schneider C, Ziegler A, Ricker K, Grimm T, Kress W, Reimers CD, Meinck H, Reiners K, Toyka KV (2000) Proximal myotonic myopathy: evidence for anticipation in families with linkage to chromosome 3q. Neurology 55:383-388
37. George A, Schneider-Gold C, Zier S, Reiners K, Sommer C (2004) Musculoskeletal pain in patients with myotonic dystrophy type 2. Arch Neurol 61:1938-1942
38. Suokas KI, Haanpaa M, Kautiainen H, Udd B, Hietaharju AJ (2012) Pain in patients with myotonic dystrophy type 2: a postal survey in Finland. Muscle Nerve 45:70-74
39. Gagnon C, Chouinard MC, Laberge L, Veillette S, Begin P, Breton R, Jean S, Brisson D, Gaudet D, Mathieu J (2010) Health supervision and anticipatory guidance in adult myotonic dystrophy type 1. Neuromuscul Disord 20:847-851
40. Mathieu J, Allard P, Gobeil G, Girard M, De Braekeleer M, Begin P (1997) Anesthetic and surgical complications in 219 cases of myotonic dystrophy. Neurology 49:1646-1650
41. Veyckemans F, Scholtes JL (2013) Myotonic Dystrophies type 1 and 2: anesthetic care. Paediatr Anaesth [Epub ahead of print]
42. Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, Pourmand R, Otten RF, Bhakta D, Nair GV, Marashdeh MM, Zipes DP, Pascuzzi RM (2008) Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 358:2688-2697
43. Groh WJ, Bhakta D (2012) Arrhythmia management in myotonic dystrophy type 1. JAMA 308:337-338
44. Sansone VA, Brigonzi E, Schoser B, Villani S, Gaeta M, De Ambroggi G, Bandera F, De Ambroggi L, Meola G (2012) The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): Long-term outcomes. Int J Cardiol [Epub ahead of print]
45. Wahbi K, Meune C, Porcher R, Becane HM, Lazarus A, Laforet P, Stojkovic T, Behin A, Radvanyi-Hoffmann H, Eymard B, Duboc D (2012) Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease. JAMA 307:1292-1301
46. Das M, Moxley RT III, Hilbert JE, Martens WB, Letren L, Greene MH, Gadalla SM (2012) Correlates of tumor development in patients with myotonic dystrophy. J Neurol 259:2161-2166
47. Gadalla SM, Lund M, Pfeiffer RM, Gortz S, Mueller CM, Moxley RT III, Kristinsson SY, Bjorkholm M, Shebl FM, Hilbert JE, Landgren O, Wohlfahrt J, Melbye M, Greene MH (2011) Cancer risk among patients with myotonic muscular dystrophy. JAMA 306:2480-2486
48. Mueller CM, Hilbert JE, Martens W, Thornton CA, Moxley RT III, Greene MH (2009) Hypothesis: neoplasms in myotonic dystrophy. Cancer Causes Control 20:2009-2020
49. Win AK, Perattur PG, Pulido JS, Pulido CM, Lindor NM (2012) Increased cancer risks in myotonic dystrophy. Mayo Clin Proc 87:130-135
50. Meola G (2010) Myotonic dystrophies as a brain disorder. Neurol Sci 31:863-864